• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Malaria - Articles and news items

KAF156

Novartis and MMV expand partnership to develop KAF156

Industry news / 15 June 2016 / Victoria White, Digital Content Producer

Novartis’ KAF156 is one of the first antimalarial drug candidates to enter Phase IIb clinical development in more than 20 years…

lariam

Lariam only to be considered as a last resort, says Defence Committee

Industry news / 24 May 2016 / Victoria White, Digital Content Producer

Lariam, the anti-malarial drug sometimes prescribed to British troops, should be considered only as a drug of last resort, says the Defence Committee…

malaria

Comic Relief and GSK team up to help fight malaria

Industry news / 15 December 2015 / Victoria White

A new fund – created through a £17m donation from GSK and £5m from Comic Relief – will provide targeted grants over the next five years to organisations on the malaria frontline…

artesunate

Crowdfunding bid to test malaria drug in cancer

Industry news / 16 October 2015 / Victoria White

Scientists investigating whether the malaria drug artesunate could have a significant impact on colorectal cancer have launched a crowdfunding project to fund their work…

Magnetic blood filter to tackle drug resistant malaria

Magnetic blood filter to tackle drug resistant malaria

Industry news / 12 August 2015 / Katie Sadler, Digital Content Producer, European Pharmaceutical Review

A magnetic blood filtering device is under development by start-up company MediSieve to capture and remove red blood cells infected with drug resistant malaria.

mosquirix

CHMP adopts positive scientific opinion of malaria vaccine Mosquirix

Industry news / 24 July 2015 / Victoria White

The CHMP has adopted a positive scientific opinion for Mosquirix, making it the first vaccine for the prevention of malaria to reach such a milestone…

malaria-coartem

Malaria treatment Coartem 80/480mg receives WHO prequalification

Industry news / 16 July 2015 / Victoria White

Coartem 80/480mg has received WHO prequalification, making it the first high strength ACT antimalarial treatment available for public sector procurement…

mosquirix

Sanofi extends collaboration with Medicines for Malaria Venture

Industry news / 8 July 2015 / Victoria White

Sanofi is to extend its collaboration with Medicines for Malaria Venture (MMV) to jointly develop a new single, fixed-dose combination therapy for malaria…

dengue

Promising malaria and dengue vaccines alone will not defeat diseases, says GlobalData Analyst

Industry news / 21 May 2015 / Victoria White

Despite optimism surrounding new dengue and a malaria vaccines, vaccination alone is not a long-term solution for combatting these diseases, says GlobalData…

rts,s

Malaria vaccine candidate RTS,S has demonstrated efficacy over 3-4 years of follow-up

Industry news / 24 April 2015 / Victoria White

Phase III trial results of the RTS,S vaccine candidate show that it helped protect children from clinical malaria for at least 3 years after vaccination…

Novartis

Novartis and Malaria No More help fulfill malaria treatment goal in Zambia by raising funds for three million treatments through Power of One

Industry news / 12 November 2014 / Novartis

Novartis announced that, through Power of One, enough funds have been raised to deliver three million antimalarial treatments for children in Zambia…

Clevexel

CleveXel Pharma partners with Guilin Pharmaceutical to develop two new anti-malarial products

Industry news / 3 September 2014 / Andrew Lloyd & Associates

CleveXel Pharma announces that the company has entered into a new partnering agreement with Guilin Pharmaceutical, a Chinese company located in Shanghai, regarding the development of two new products…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +